IT1197061B - Composizioni farmaceutiche ad azione vasodilatatrice e antianossica - Google Patents

Composizioni farmaceutiche ad azione vasodilatatrice e antianossica

Info

Publication number
IT1197061B
IT1197061B IT21393/86A IT2139386A IT1197061B IT 1197061 B IT1197061 B IT 1197061B IT 21393/86 A IT21393/86 A IT 21393/86A IT 2139386 A IT2139386 A IT 2139386A IT 1197061 B IT1197061 B IT 1197061B
Authority
IT
Italy
Prior art keywords
vasodilater
antianoxic
action
pharmaceutical compositions
pharmaceutical
Prior art date
Application number
IT21393/86A
Other languages
English (en)
Other versions
IT8621393A1 (it
IT8621393A0 (it
Inventor
Pierre Noel Brasey
Original Assignee
Seuref Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seuref Ag filed Critical Seuref Ag
Publication of IT8621393A0 publication Critical patent/IT8621393A0/it
Publication of IT8621393A1 publication Critical patent/IT8621393A1/it
Application granted granted Critical
Publication of IT1197061B publication Critical patent/IT1197061B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
IT21393/86A 1985-08-02 1986-08-01 Composizioni farmaceutiche ad azione vasodilatatrice e antianossica IT1197061B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH3344/85A CH670763A5 (it) 1985-08-02 1985-08-02

Publications (3)

Publication Number Publication Date
IT8621393A0 IT8621393A0 (it) 1986-08-01
IT8621393A1 IT8621393A1 (it) 1988-02-01
IT1197061B true IT1197061B (it) 1988-11-25

Family

ID=4253937

Family Applications (1)

Application Number Title Priority Date Filing Date
IT21393/86A IT1197061B (it) 1985-08-02 1986-08-01 Composizioni farmaceutiche ad azione vasodilatatrice e antianossica

Country Status (9)

Country Link
US (1) US4778798A (it)
JP (1) JPS6253932A (it)
BE (2) BE905198A (it)
CH (1) CH670763A5 (it)
DE (1) DE3625877A1 (it)
FR (1) FR2591481B1 (it)
GB (1) GB2178314B (it)
IT (1) IT1197061B (it)
NL (1) NL8601977A (it)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH662505A5 (it) * 1985-04-30 1987-10-15 Seuref Ag Composizioni farmaceutiche ad azione protettiva vascolare.
US4871731A (en) * 1987-10-07 1989-10-03 Marion Laboratories, Inc. Captopril and diltiazem composition and the like
JPH02188523A (ja) * 1989-01-13 1990-07-24 M S C:Kk 睡眠時無呼吸症治療薬
DE3918082A1 (de) * 1989-06-02 1991-01-24 Max Planck Gesellschaft Mittel gegen autoimmunerkrankungen
FR2655854A1 (fr) * 1989-12-19 1991-06-21 Poissonnet Claude Medication nouvelle pour le traitement de surcharges lipidiques.
US5145859A (en) * 1991-03-20 1992-09-08 Case Western Reserve University Methods of treating interstitial cystitis and urethral syndrome
US6461593B1 (en) * 1992-02-19 2002-10-08 Biomedical And Clinical Research Therapy with coenzyme Q10 to reduce subgingival microorganisms in patients with periodontal disease
IT1265312B1 (it) * 1993-12-21 1996-10-31 Indena Spa Formulazioni contenenti carotenoidi e procarotenoidi associati a polifenoli nella prevenzione dei danni da abnorme produzione di
US5660835A (en) * 1995-02-24 1997-08-26 East Carolina University Method of treating adenosine depletion
US20020032160A1 (en) * 1995-02-24 2002-03-14 Nyce Jonathan W. Compositions & formulations with an epiandrosterone or a ubiquinone & kits & their use for treatment of asthma symptoms & for reducing adenosine/adenosine receptor levels
US6133322A (en) * 1998-10-29 2000-10-17 Institut National De La Sante Et De La Recherche Medicale (Inserm) Quinone derivatives for treating or preventing diseases associated with iron overload
DE19928528C2 (de) * 1999-06-22 2002-10-17 Heinz Kiefer Arzneimittel (Antiarteriosklerotikum) zur Vorbeugung und Linderung von Beschwerden bei arteriellen Durchblutungsstörungen auf der Grundlage von Ginkgobiloba
GB2368012A (en) 2000-10-19 2002-04-24 Nicholas John Larkins Preparation for the relief of inflammatory disease
GB0209254D0 (en) * 2002-04-23 2002-06-05 Larkins Nicholas J Preparation for the relief of disease

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5938203B2 (ja) * 1976-04-26 1984-09-14 エーザイ株式会社 補酵素ｑを主成分とする脳循環障害治療剤
JPS5913710A (ja) * 1982-07-15 1984-01-24 Shiseido Co Ltd 養毛料
CH655005A5 (it) * 1983-02-16 1986-03-27 Sigma Tau Ind Farmaceuti Composizione farmaceutica ad azione metabolica ed energetica utilizzabile in terapia cardiaca e vascolare.

Also Published As

Publication number Publication date
GB2178314A (en) 1987-02-11
JPS6253932A (ja) 1987-03-09
FR2591481A1 (fr) 1987-06-19
IT8621393A1 (it) 1988-02-01
US4778798A (en) 1988-10-18
NL8601977A (nl) 1987-03-02
FR2591481B1 (fr) 1992-05-29
DE3625877C2 (it) 1992-04-02
DE3625877A1 (de) 1987-02-05
CH670763A5 (it) 1989-07-14
GB8618249D0 (en) 1986-09-03
IT8621393A0 (it) 1986-08-01
BE905211A (nl) 1987-02-04
BE905198A (nl) 1986-11-17
GB2178314B (en) 1990-02-21

Similar Documents

Publication Publication Date Title
BR1100036A (pt) Composto e composição farmacêutica
IT1201412B (it) Composizioni farmaceutiche ad azione antianossica e metabolica cerebrale
DK151686D0 (da) Hydroxamater
DE3486441T2 (de) 3-Hydroxypyrid-4-one und pharmazeutische Zusammensetzungen
IT1191608B (it) Composizione farmaceutica e forme farmaceutiche che la contengono
MX163529B (es) Composicion quimicoluminiscente
IT8822018A0 (it) Dipeptidi fosfinilcicloalchilcarbonilici e fosfonilcicloalchenilcarbonilici ad azione farmaceutica
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
DE3671446D1 (de) 5-aralkylsubstituierte 2h-benztriazole und stabilisierte zusammensetzungen.
IT1209615B (it) Composizione farmaceutica
IT1229176B (it) Antibiotici antitumorali bbm-1675c e d
IT1197811B (it) 2h-benzotriazoli 5-superiore alchil-sostituiti e composizioni stabilizzate
IT1200603B (it) Composizione farmaceutiche ad attivita dopaminergica
RO96327A (ro) Compozitie nematocida si insecticida
DK488185D0 (da) N6-benzopyrano- og benzothiopyranoadenosiner
IT8547704A1 (it) Diazepinoindoli loro preparazione e loro impiego come medicamenti
IT1200467B (it) Formulazione farmaceutica
IT1203737B (it) Composizioni farmaceutiche comprendenti 3-amminopropossi-indoli
FR2588259B1 (fr) Bis-acridiniques monopontes et bis-acridiniques bipontes
IT1190383B (it) Sostanze peptidominetiche ad azione ipotensiva
IT8667509A0 (it) Composizione alghicida e erbicida
BR1100961A (pt) Composto e composição farmacêutica
IT8520966A0 (it) Composizioni alimentari e farmaceutiche ad attivita'immunostimolante.
IT8521323A0 (it) Xantinilmetil-tiazolidine e composizioni farmaceutiche che le contengono.
BR6500407U (pt) Composicao medicinal